Navigation Links
Meckel's diverticulum masked by intermittent recurrent subocclusive episodes
Date:6/23/2009

Meckel's diverticulum (MD) is the most frequent congenital abnormality of the small bowel and it is often difficult to diagnose. It is usually asymptomatic but approximately 4% are symptomatic with complications such as bleeding, intestinal obstruction, and inflammation. Daniela Codrich et al presents a case of Meckel's diverticulum masked by a long period of intermittent recurrent subocclusive episodes. Their foundings will be published on June 14, 2009 in the World Journal of Gastroenterology.

In this case, a 7-year-old boy presented with repeated episodes of periumbilical pain with associated vomiting which resolved spontaneously in a few hours. The frequency of the episodes increased from one per month to weekly and then daily vomiting, but painless hemorrhage, the classical presenting symptom of Meckel's diverticulum, was never experienced. These symptoms were firstly interpreted as cyclic vomiting of childhood. Only the persistence of the condition accompanied by weight loss prompted physicians to investigate further. A supravesical mass was found with ultrasound and confirmed by magnetic resonance. However, the final diagnosis was only made at laparoscopy.

This article seeks to emphasize that preoperative diagnosis of a complicated Meckel's diverticulum can be challenging and often difficult to establish because clinical symptoms and imaging features overlap with those of other disorders causing acute abdominal pain or gastrointestinal bleeding (in cases where hemorrhage is present). The case also underlines the utmost importance of laparoscopy as a diagnostic and, at the same time, a therapeutic tool in the pediatric population.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Unmasked and vulnerable
2. New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research
3. Intermittent Catheter Market to Surpass 40% CAGR Between 2008 and 2012
4. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
5. New approach for treating recurrent prostate cancer on the horizon
6. New treatment shows promise against recurrent gynecologic cancers
7. Avastin effective at delaying brain tumor progression in recurrent disease
8. Research shows biopsy of recurrent breast cancer can alter treatment
9. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
10. Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
11. Radiation therapy prolongs life in men with recurrent prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges the ... how his administration could impact the employee benefits industry. James Slotnick, AVP, Government ... likely to make it through Congress. His discussion will focus on the current ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would ... results in a fraction of the time as traditional braces – Wilckodontics®. Dr. ... Specialists, now offers this revolutionary treatment with or without a referral. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South Florida ... report in the May issue of Consumer Reports focused on heart health. , ... achieved during and after coronary bypass and aortic valve replacement procedures. , Consumer ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine ... telehealth bundles, which pairs medical devices with a pre-programmed tablet in a remarkably ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
Breaking Medicine Technology: